Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
Apply
Ixo-vec
Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step